A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT04565717 · TERMINATED
Trial details
- NCT number
- NCT04565717
- Sponsor
- Alnylam Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-09
- Primary completion
- 2023-01-06
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.